Voloridge Investment Management, LLC Alx Oncology Holdings Inc Transaction History

Voloridge Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$8.23 - $15.14 $746,938 - $1.37 Million	-90,758 Reduced 66.33%	46,070 $441,000
Q2 2022 Aug 15, 2022	SELL	$5.89 - $19.46 $447,693 - $1.48 Million	-76,009 Reduced 35.71%	136,828 $1.11 Million
Q1 2022 May 16, 2022	BUY	$13.65 - $22.06 $638,478 - $1.03 Million	46,775 Added 28.17%	212,837 $3.6 Million
Q4 2021 Feb 14, 2022	BUY	$21.49 - $74.4 $3.57 Million - $12.4 Million	166,062 New	166,062 $3.57 Million
Q3 2021 Nov 15, 2021	SELL	$52.51 - $80.91 $3.14 Million - $4.85 Million	-59,891 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$52.2 - $75.23 $2.72 Million - $3.92 Million	52,109 Added 669.61%	59,891 $3.28 Million
Q1 2021 May 17, 2021	BUY	$62.84 - $87.68 $489,020 - $682,325	7,782 New	7,782 $574,000

101

39.7M

134K

17.4K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $68.9M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.